Artificial Cells Nanomedicine and Biotechnology

Scope & Guideline

Exploring the Frontiers of Biotechnology and Nanomedicine.

Introduction

Immerse yourself in the scholarly insights of Artificial Cells Nanomedicine and Biotechnology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2169-1401
PublisherTAYLOR & FRANCIS LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationARTIF CELL NANOMED B / Artif. Cell. Nanomed. Biotechnol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Artificial Cells Nanomedicine and Biotechnology' focuses on the intersection of nanotechnology, biotechnology, and medicine, highlighting innovative research aimed at developing artificial cells and nanoparticles for therapeutic applications.
  1. Nanoparticle Synthesis and Characterization:
    The journal emphasizes the synthesis and characterization of various nanoparticles, particularly those derived from natural sources, highlighting their potential applications in drug delivery, antibacterial properties, and cancer treatment.
  2. Biocompatibility and Therapeutic Applications:
    Research on the biocompatibility of nanoparticles and their therapeutic applications is a core focus, with studies investigating how these materials can be effectively used in medical treatments.
  3. Cancer Research and Treatment:
    A significant portion of the journal's articles is dedicated to cancer research, exploring novel drug delivery systems, photodynamic therapy, and the role of nanoparticles in enhancing therapeutic efficacy.
  4. Microbiome and Metabolomics:
    The journal also addresses the interaction between nanoparticles and biological systems, including studies on the gut microbiome and its influence on health, as well as metabolomics-related research.
  5. Innovative Drug Delivery Systems:
    The development of advanced drug delivery systems, including liposomes, micelles, and other novel carriers for targeted and controlled release, is a prominent theme in the journal's publications.
  6. Environmental and Green Chemistry:
    Research on environmentally friendly synthesis methods for nanoparticles, emphasizing sustainability and reduced toxicity, is increasingly featured in the journal.
The journal is witnessing a surge in interest in several emerging themes, reflecting advancements in technology and shifting research priorities.
  1. Artificial Cells and Biomimetic Systems:
    Research on artificial cells and biomimetic systems is gaining momentum, highlighting innovative approaches to drug delivery and therapeutic interventions.
  2. Nanotechnology in Regenerative Medicine:
    The application of nanotechnology in regenerative medicine is emerging as a key theme, with studies exploring the use of nanoparticles for tissue engineering and regenerative therapies.
  3. Machine Learning and Bioinformatics Applications:
    There is an increasing trend towards integrating machine learning and bioinformatics in research, particularly in the analysis of complex biological data and the development of predictive models in medicine.
  4. Therapeutic Nanoparticles for Infectious Diseases:
    The journal is seeing a rise in publications focused on the use of nanoparticles for combating infectious diseases, particularly in the context of recent global health challenges.
  5. Personalized Medicine Approaches:
    Emerging studies are increasingly focusing on personalized medicine, utilizing nanoparticles and artificial cells to tailor treatments based on individual patient profiles.

Declining or Waning

While certain themes remain prominent, others appear to be losing traction within the journal, reflecting changing research priorities and interests in the field.
  1. Traditional Chemical Synthesis Methods:
    There is a noticeable decline in articles focusing on traditional chemical synthesis methods for nanoparticles, as the field increasingly shifts towards greener, more sustainable approaches.
  2. Basic Mechanistic Studies without Application:
    Research that centers solely on basic mechanistic studies without direct applications in nanomedicine or biotechnology is becoming less frequent, with a growing preference for studies that demonstrate practical therapeutic relevance.
  3. In Vitro Studies without In Vivo Validation:
    Papers that only present in vitro findings without subsequent in vivo validation are diminishing, as the journal increasingly prioritizes studies that bridge laboratory findings with clinical implications.

Similar Journals

DRUG DELIVERY

Empowering Researchers with Open Access to Knowledge
Publisher: TAYLOR & FRANCIS LTDISSN: 1071-7544Frequency: 1 issue/year

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

MOLECULES

Discovering the Future of Chemistry, One Molecule at a Time
Publisher: MDPIISSN: Frequency: 24 issues/year

MOLECULES, published by MDPI, stands as a prominent open-access journal dedicated to the field of chemistry, with an exceptional reputation in various sub-disciplines. Since its inception in 1997, this journal has committed itself to the dissemination of innovative research, spanning topics in Analytical Chemistry, Organic Chemistry, Pharmaceutical Science, and Drug Discovery. With impressive rankings across Scopus categories—including a coveted Q1 designation in both Analytical Chemistry and Pharmaceutical Science—MOLECULES is recognized as a vital resource for researchers, professionals, and students aiming to stay at the forefront of scientific development. The journal’s data reflect its wide-ranging influence, holding high percentiles in multiple chemistry categories, thereby ensuring that its articles reach a significant audience. As an open-access journal, it provides unparalleled access to its content, available freely and globally, which promotes further advancement and collaboration within the scientific community. Its ongoing commitment to high-quality research from 1996 to 2024 reinforces its status as a leader in the academic publishing landscape.

Nanomedicine Journal

Bridging Science and Medicine at the Nanoscale.
Publisher: MASHHAD UNIV MED SCIENCESISSN: 2322-3049Frequency: 4 issues/year

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

JOURNAL OF NANOPARTICLE RESEARCH

Pioneering Research at the Atomic and Molecular Level
Publisher: SPRINGERISSN: 1388-0764Frequency: 1 issue/year

JOURNAL OF NANOPARTICLE RESEARCH, published by SPRINGER, is a pivotal platform in the interdisciplinary field of nanotechnology, encompassing atomic and molecular physics, bioengineering, chemistry, condensed matter physics, and materials science. Operating since 1999 and converging through 2024, this journal presents cutting-edge research and innovations in nanoparticle science, aiming to bridge theoretical studies with practical applications. With a diverse scope that attracts articles ranked in various Q2 and Q3 category quartiles across its fields, including Bioengineering and Nanoscience and Nanotechnology, it ranks favorably within Scopus metrics, ensuring high visibility and impact among researchers. While the journal operates under traditional access models, it remains a critical resource for professionals and students alike, empowering them to advance their knowledge and drive future discoveries in this rapidly evolving area of study.

ADVANCED DRUG DELIVERY REVIEWS

Unveiling the Future of Drug Delivery.
Publisher: ELSEVIERISSN: 0169-409XFrequency: 12 issues/year

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

Nano Today

Catalyzing discoveries that shape tomorrow's innovations.
Publisher: ELSEVIER SCI LTDISSN: 1748-0132Frequency: 6 issues/year

Nano Today is a prestigious journal published by ELSEVIER SCI LTD that stands at the forefront of nanoscience and nanotechnology research. With an impact factor that underscores its significance, this journal has achieved remarkable rankings in several key categories as of 2023, including Q1 positions in Bioengineering, Biomedical Engineering, Biotechnology, Materials Science, and Pharmaceutical Science, making it an essential resource for scholars and professionals alike. ISSN 1748-0132 and E-ISSN 1878-044X, the journal serves as a vital platform for disseminating cutting-edge research findings and innovative applications in the field. Although open access options are not available, the journal's rich repository of peer-reviewed articles provides invaluable insights into the latest advancements in nanotechnologies. Based in the Netherlands, Nano Today not only connects a global network of researchers but also propels forward the conversation on the transformative potential of nanomaterials across multiple disciplines. With a commitment to advancing knowledge and fostering innovation, Nano Today is an indispensable tool for academics and practitioners dedicated to pushing the boundaries of scientific exploration.

BIOMATERIALS

Illuminating the Path to Next-Gen Biomaterials
Publisher: ELSEVIER SCI LTDISSN: 0142-9612Frequency: 36 issues/year

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION

Advancing Understanding of Particle Dynamics
Publisher: WILEY-V C H VERLAG GMBHISSN: 0934-0866Frequency: 12 issues/year

PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION is a distinguished journal dedicated to advancing the knowledge within the fields of Chemistry, Condensed Matter Physics, and Materials Science. Published by WILEY-V C H VERLAG GMBH in Germany, this journal has established a solid reputation since its inception in 1984, showcasing research aimed at understanding the intricate properties and behaviors of particulate systems. With an impressive Q2 ranking in its respective categories and Scopus ranks indicating a robust standing in the global research community, it serves as an essential resource for researchers, professionals, and students. Although it does not currently offer Open Access options, its comprehensive articles and reviews provide valuable insights that contribute significantly to the ongoing discourse in these scientific domains. As it prepares to celebrate four decades of publication, PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION continues to provide a vital platform for emerging knowledge, fostering innovation and collaboration among scientists dedicated to the study of particle systems.

Biomaterials Research

Transforming research into real-world applications.
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 1226-4601Frequency: 1 issue/year

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

International Journal of Polymeric Materials and Polymeric Biomaterials

Advancing Research in Polymeric Innovations
Publisher: TAYLOR & FRANCIS ASISSN: 0091-4037Frequency: 18 issues/year

The International Journal of Polymeric Materials and Polymeric Biomaterials, published by Taylor & Francis AS, stands at the forefront of materials science, showcasing groundbreaking research in the fields of Analytical Chemistry, Chemical Engineering, and Polymeric Materials. With an ISSN of 0091-4037 and an E-ISSN of 1563-535X, this esteemed journal, established in 1971, serves as a vital platform for academics and professionals seeking to disseminate innovative findings and elevate the understanding of polymeric materials. Featuring a commendable impact factor and ranking in the top quartiles of its categories—Q2 in Analytical Chemistry, Chemical Engineering, and Polymers and Plastics—the journal is a pivotal resource for researchers aiming to leverage polymer science in various applications. Although it does not offer open access, its rigorous peer-review process ensures that only high-quality research is published, making it an essential reference for anyone involved in polymer research and development.